1. Signaling Pathways
  2. GPCR/G Protein
  3. Formyl Peptide Receptor (FPR)
  4. Formyl Peptide Receptor (FPR) Inhibitor

Formyl Peptide Receptor (FPR) Inhibitor

Formyl Peptide Receptor (FPR) Inhibitors (4):

Cat. No. Product Name Effect Purity
  • HY-P10738A
    N-Formyl-MMYALF TFA
    Inhibitor
    N-Formyl-MMYALF TFA is a mitochondrial N-formyl peptide that has the activity of depleting calcium ions in the endoplasmic reticulum. N-Formyl-MMYALF TFA can inhibit the FPR-1-mediated chemotactic response of PMNs to bacterial peptides.
  • HY-P5469
    WRW4-OH
    Inhibitor
    WRW4-OH is a biological active peptide. (This peptide inhibits binding of one of formyl peptide receptor-like 1 (FPRL1) agonists WKYMVm to its specific receptor. FPRL1 is an important classical chemoattractant receptor that is expressed in phagocytic cells in the peripheral blood and brain. Activation of FPRL1 is closely related to inflammatory responses in the host defense mechanism and neurodegenerative disorders.)
  • HY-P10738
    N-Formyl-MMYALF
    Inhibitor 99.59%
    N-Formyl-MMYALF is a potent mitochondrial N-formyl peptide (mtFP) that has the activity of depleting calcium ions in the endoplasmic reticulum. N-Formyl-MMYALF can inhibit the FPR-1-mediated chemotactic response of polymorphonuclear leukocytes (PMNs) to bacterial peptides.
  • HY-117971
    BVT173187
    Inhibitor
    BVT173187 is a selective inhibitor of the neutrophil formyl peptide receptor FPR1, with activity that inhibits FPR1 activation. BVT173187 inhibits FPR1 agonist-induced activation in neutrophils, reduces adhesion molecule mobilization and superoxide anion production, and has inhibitory activity on FPR1 similar to that of earlier described peptide antagonists, but also has effects on C5aR and CXCR signaling.